Skip to main content

. 1973 Mar;66(3):263–266. doi: 10.1177/003591577306600331

Migraine--a personal view.

PMCID: PMC1644845 PMID: 4697994

263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DALTON K. Early symptoms of pre-eclamptic toxaemia. Lancet. 1960 Jan 23;1(7117):198–199. doi: 10.1016/s0140-6736(60)90113-6. [DOI] [PubMed] [Google Scholar]
Dalton K. Progesterone suppositories and pessaries in the treatment of menstrual migraine. Headache. 1973 Jan;12(4):151–159. doi: 10.1111/j.1526-4610.1973.hed1204151.x. [DOI] [PubMed] [Google Scholar]
Hannington E. Preliminary report on tyramine headache. Br Med J. 1967 May 27;2(5551):550–551. doi: 10.1136/bmj.2.5551.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
Johansson E. D. Depression of the progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol (Copenh) 1971 Dec;68(4):779–792. doi: 10.1530/acta.0.0680779. [DOI] [PubMed] [Google Scholar]
Sjaastad O., Stensrud P. 2-(2.6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155 or Catapresan) as a prophylactic remedy against migraine. Acta Neurol Scand. 1971;47(1):120–122. doi: 10.1111/j.1600-0404.1971.tb07470.x. [DOI] [PubMed] [Google Scholar]
Smith I., Kellow A. H., Mullen P. E., Hanington E. Dietary migraine and tyramine metabolism. Nature. 1971 Mar 26;230(5291):246–248. doi: 10.1038/230246a0. [DOI] [PubMed] [Google Scholar]
Wilkinson M. Clonidine for migraine. Lancet. 1969 Aug 23;2(7617):430–430. doi: 10.1016/s0140-6736(69)90131-7. [DOI] [PubMed] [Google Scholar]
Youdim M. B., Carter S. B., Hanington E., Wilkinson M., Sandler M. Conjugation defect in tyramine-sensitive migraine. Nature. 1971 Mar 12;230(5289):127–128. doi: 10.1038/230127a0. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES